This #MentalHealthAwarenessMonth, we’ve partnered with actor, author, podcast host, and mother Busy Philipps to share her personal journey with #ADHD! Read more about Busy’s story here: bit.ly/4dhXmzx
Supernus Pharmaceuticals, Inc.
Pharmaceutical Manufacturing
Rockville, Maryland 16,432 followers
About us
We are a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Our extensive expertise in product development has been built over the past 30 years: initially as a standalone development organization, then as a U.S. subsidiary of Shire plc and, in late 2005, as Supernus Pharmaceuticals Inc. We market our products in the United States through our own specialty sales force and seek strategic collaborations with other pharmaceutical companies to license our products outside the United States. We market Qelbree® (viloxazine extended-release) for the treatment of attention deficit/hyperactivity disorder (ADHD) in children ages 6 to 17. Trokendi XR® (extended-release topiramate) for the prophylaxis of migraine and the treatment of epilepsy, Oxtellar XR® (extended-release oxcarbazepine) for the treatment of epilepsy, Apokyn® (apomorphine hydrochloride injection) for the acute treatment of hypomobility in advanced Parkinson’s disease (PD), Myobloc® (rimabotulinumtoxinB) for the treatment of cervical dystonia and treatment of chronic sialorrhea in adults, and Xadago® (safinamide) as an adjunctive treatment to levodopa/carbidopa in PD patients with hypomobility. We are also developing several product candidates to address large market opportunities in the CNS market, including SPN-812 for the treatment of ADHD in adults, apomorphine infusion pump for hypomobility in PD, SPN-820 (NV-5138) for treatment-resistant depression, and SPN-817 for the treatment of epilepsy.
- Website
-
http://www.supernus.com
External link for Supernus Pharmaceuticals, Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Rockville, Maryland
- Type
- Public Company
- Founded
- 2005
- Specialties
- CNS, Epilepsy, Migraine, Parkinson's Disease, Cervical Dystonia, and Chronic Sialorrhea
Locations
-
Primary
9715 Key West Ave
Rockville, Maryland 20850, US
Employees at Supernus Pharmaceuticals, Inc.
-
Pete Currie
Director Corporate Accounts at Supernus Pharmaceuticals, Inc.
-
Henry Anderson
-
Suzanne Henderson, PHR
-
Bethany Sensenig, MBA, CMA
Chief Financial Officer | C-Suite Executive | Board Member | Corporate Strategy | Capital Structuring | Fundraising & Investor Relations | Business…
Updates
-
Thank you to the American Academy of Neurology (AAN) for an amazing Annual Meeting! It's truly an honor to be part of this community of neurologists and neuroscience professionals, providing invaluable education and collaboration, especially during #ParkinsonsAwarenessMonth. We truly believe in the power of our science and making a difference in the #ParkinsonsDisease (PD) community. Our commitment to supporting those living with #PD, their care partners and healthcare professionals remains steadfast, not only this month, but always. Discover more about our research and treatment options: bit.ly/3wfyzeD
-
According to a recent survey from the PMD Alliance (Parkinson & Movement Disorder Alliance), people with Parkinson’s (PwP) and their care partners (CPs) are facing more challenges than ever when discussing symptoms such as dyskinesia and OFF episodes during their appointments. As healthcare providers, it's imperative to initiate these discussions with a profound understanding and awareness of emerging treatment options to better address the needs of those affected by #PD. Join us in sparking discussions around navigating PD treatment: bit.ly/448Uqkp #BeIcONicwithPD #TakeActiON #ParkinsonsAwarenessMonth
-
Recent statistics underscore the issues those with #PD are facing, like increased OFF time, highlighting the need for continuous, all-day treatment. At Supernus, we're dedicated to addressing the variability in the daily lives of those with #ParkinsonsDisease, offering them much-needed consistency amidst fluctuating symptoms. Discover how our recent research and development efforts are shaping the future of Parkinson's care: bit.ly/3TZMk94 #BeIcONicwithPD #TakeActiON #ParkinsonsAwarenessMonth
-
Despite its prevalence, #AdultADHD is often overlooked. We're dedicated to bridging the gap in diagnosis by focusing on education and patient-centered care. Through these efforts, we aim to improve detection rates and enhance outcomes for individuals with adult ADHD. Together, let's prioritize adult #ADHD awareness and support: bit.ly/3PPohZn
-
Meet Dr. Sasha Hamdani, an advocate for patient-centered #ADHD care. With a keen understanding that ADHD can manifest differently across the lifespan, Dr. Hamdani emphasizes the importance of open dialogue between patients and providers. Whether diagnosed as a child or adult, fostering a trusting relationship allows for meaningful discussions about symptoms, challenges, and personalized treatment approaches. Together, let's navigate conversations around ADHD with compassion and collaboration: bit.ly/3TsF99o
-
Embrace the arrival of spring by encouraging patients with #ParkinsonsDisease to incorporate outdoor exercise into their routines. As the weather warms, outdoor activities like walking, gardening, and Tai Chi can invigorate both the body and mind. Let's harness the rejuvenating power of nature to enhance mobility and quality of life for individuals living with #PD! For more tips on increasing GOOD ON time with Parkinson’s, visit: bit.ly/4acSVUa #BeIcONicwithPD #TakeActiON
-
Recognizing the gender specific presentations of #ADHD is essential in clinical practice. Women may manifest subtler signs of inattention, contributing to underdiagnosis and undertreatment. Let's prioritize awareness and nuanced assessment to ensure equitable care for all patients with ADHD! For more information, visit: bit.ly/3TsZcWm
-
Dive into the complexities of #ParkinsonsDisease, as we explore the nuanced interplay between motor and nonmotor symptoms. Understanding these dynamics is crucial for tailoring patient care and advancing treatment strategies. For more information around symptom management and maximizing good ON time, visit: bit.ly/3P80PWO
-
We recently had the honor of hosting a product theater at the 29th Annual National Psychopharmacology Update in Nevada where we shared insights and innovations in psychopharmacology, contributing to enhanced patient care. Thank you to all who joined us! Check out how Supernus is dedicated to developing novel treatments for #CNS conditions: bit.ly/42S11iK